Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Total 13F shares
-
35,950,832
-
Share change
-
+35,950,832
-
Total reported value
-
$1,126,753,000
-
Price per share
-
$31.61
-
Number of holders
-
38
-
Value change
-
+$1,126,753,000
-
Number of buys
-
38
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q2 2020
As of 30 Jun 2020,
Vaxcyte, Inc. - COMMON STOCK (PCVX) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,950,832 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., TPG Group Holdings (SBS) Advisors, Inc., JANUS HENDERSON GROUP PLC, FMR LLC, Abingworth LLP, FRAZIER MANAGEMENT LLC, Medicxi Ventures Management (Jersey) Ltd, WELLINGTON MANAGEMENT GROUP LLP, NOVO Holdings A/S, and MILLENNIUM MANAGEMENT LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.